Global Microbiome Sequencing Services Market Overview
Introduction:
Microbiome Sequencing Services Market was valued at US$ 4.6 billion in 2024 and is projected to grow at a CAGR of 19.4% to reach US$ 27.1billion by 2034.
The unique collection of trillions of microorganisms on the individual’s body is called the microbiome. The human microbiome aims to study the role of microbes on health and disease. Human microbiome analysis is the study of microbial communities found in the human body. The ribosomal RNA gene sequencing can be used to process environmental and clinical samples and can serve a various purpose from food quality assurance for the microbiota research. The study of genetic material obtained directly from microbes is referred to as microbiome sequencing. Microbiome sequencing uses many approaches to collect human biodata in order to better understand sickness. It is the investigation of bacteria found in the human gut with the objective of better understanding human microbes and their function in health and disease. Previously, traditional microbiological procedures were employed to examine an individual's phenotype and genotype by obtaining samples from the skin, blood, or stool. Tools like next-generation testing are being utilised to generate human microbiome data as technology advances.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Microbiome Sequencing Services Market Dynamics
The huge investment in microbiome research by the industries is the major driving factor for the growth of the market. Additionally, the increase in the demand for the next gene sequencing services which is another propelling factor for the growth of the target market. Also, the reduction in the cost of the next gene sequencing fuels the growth of the market. Moreover, the surge in the genomic research and widening application area of the microbiome sequencing which is the boosting factor for the growth of the target market. The NIAID (National Institute of Allergy and Infectious Diseases) microbiome sequencing program involves the study and analysis of functional and structural specification, associated with concerned body sites and host organisms. However, the ethical and legal issues related to genome and microbiome sequencing which is the major restraining factor for the growth of the market. Furthermore, the lack of skilled technicians for the next gene sequencing analysis which is another hampering factor for the growth of the market. Nevertheless, reducing the issues related to data management can create an opportunity for the growth of the target market.
Global Microbiome Sequencing Services Market Segmentation
The microbiome sequencing services market is segmented based on technology, application, end-user, and region.
Based on technology, the surgical stapler market is segmented into the sequencing by ligation (SBL), sequencing by synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and other technologies. Based on the application, the target market is segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others. Based on end-user, the target market is bifurcated into research and academic institutes, pharmaceutical and biotechnology companies, and other end users. Pharmaceutical and biotechnology companies are the most dominating segment in the microbiome sequencing services due to increasing their focus on the microbiome R&D.
Region Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Based on the region the surgical stapler market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Europe region accounts highest revenue share to the microbiome sequencing services market due to the growing incidence of cancer. North America region is projected to register a high CAGR over the forecast period owing to the growing trend of the NGS which helps to recover cancer and the joint infections.
Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 4.6 billion |
|
Projected Market Size 2034 |
US$ 27.1 billion |
|
CAGR Growth Rate |
19.4% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Technology - Sequencing by Ligation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Other Technologies By Application - Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others By End- User - Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Microbiome Sequencing Services Market report based on technology, application, end-user, and region.
Microbiome Sequencing Services Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Microbiome Sequencing Services Market, By Technology
- Middle East & Africa Microbiome Sequencing Services Market, By Application
- Middle East & Africa Microbiome Sequencing Services Market, By End- User
- Middle East & Africa Microbiome Sequencing Services Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Microbiome Sequencing Services Market, By Technology
- Latin America Microbiome Sequencing Services Market, By Application
- Latin America Microbiome Sequencing Services Market, By End- User
- Latin America Microbiome Sequencing Services Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Microbiome Sequencing Services Market, By Technology
- Asia Pacific Microbiome Sequencing Services Market, By Application
- Asia Pacific Microbiome Sequencing Services Market, By End- User
- Asia Pacific Microbiome Sequencing Services Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Microbiome Sequencing Services Market, By Technology
- Europe Microbiome Sequencing Services Market, By Application
- Europe Microbiome Sequencing Services Market, By End- User
- Europe Microbiome Sequencing Services Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Microbiome Sequencing Services Market, By Technology
- North America Microbiome Sequencing Services Market, By Application
- North America Microbiome Sequencing Services Market, By End- User
- North America Microbiome Sequencing Services Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global Microbiome Sequencing Services Market Key Players
The key players operating the Microbiome Sequencing Services Market includes, Baseclear BV, Clinical Microbiomics A/S, Merieux Nutrisciences, Jennewein Biotechnologie, Microbiome Insights Inc., Microbiome Therapeutics LLC, MR DNA, Second Genome, Ubiome Inc., and Zymo Research Corp.
Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the technology to gain a competitive edge in the target market. For instance, in 2018, Jennewein Biotechnologie launched its clinical study, to investigate the development of the infant microbiome, the impact of breastfeeding, and human milk oligosaccharides (HMOs).
Global Microbiome Sequencing Services Market Key Issues Addressed
Recent Development:
- In May 2023, iD Fresh Food, a Bangalore based fresh food brand, launched Id Frozen Fruit Blend, made from fresh fruit extracts without any preservatives available in UAE market. It is available in seven flavors: Mango, Chikoo, Pineapple, Tender Coconut, Strawberry, Grapes, and Guava. This product solves the inconvenience of peeling/cutting fruits to make shakes/smoothies. It solves the problem of round the year's unavailability of some favorite fruits without compromising the food's nutritional aspects/health aspects.
- In October 2023, BRT, an Italian delivery company launched a new service, BRT Fresh, a new service specializing the delivery of fresh food products. BRT Fresh offers a number of features that are designed to ensure that fresh food products are delivered to customers in optimal condition and on time.
- In November 2023, SPAR ENJOY, the new healthy food-to-go launched by SPAR International offering a variety of fresh, easy, and delicious meals to encourage a healthy lifestyle while on the go. Using only natural, fresh products, SPAR ENJOY serves breakfast, lunch, and dinner to patrons all day long.
Global Microbiome Sequencing Services Market Company Profile
- Baseclear BV
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
- Clinical Microbiomics A/S
- Merieux Nutrisciences
- Jennewein Biotechnologie
- Microbiome Insights Inc.
- Microbiome Therapeutics LLC
- MR DNA
- Second Genome
- Ubiome Inc.
- Zymo Research Corp.
“*” marked represents similar segmentation in other categories in the respective section
Global Microbiome Sequencing Services Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Industry Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Microbiome Sequencing Services Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End- User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Technology, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Sequencing by Ligation (SBL)
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Sequencing by Ligation (SBL)
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Short Gun Sequencing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Targeted Gene Sequencing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- RNA Sequencing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Other Technologies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Application, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Gastrointestinal Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Infectious Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- CNS Diseases
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Oncology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By End- User, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Research and Academic Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Pharmaceutical and Biotechnology Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Other End-User
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By End- User, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By End- User, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By End- User, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By End- User, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Bn), By End- User, 2020 – 2030
- Market Size and Forecast (US$ Bn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Baseclear BV
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategy
- Clinical Microbiomics A/S
- Merieux Nutrisciences
- Jennewein Biotechnologie
- Microbiome Insights Inc.
- Microbiome Therapeutics LLC
- MR DNA
- Second Genome
- Ubiome Inc.
- Zymo Research Corp.
- Baseclear BV
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The microbiome sequencing services market is segmented based on technology, application, end-user, and region.
The major drivers for the microbiome sequencing services market include huge investment in microbiome research.
North America region is projected to register a high CAGR over the forecast period owing to the growing trend of the NGS which helps to recover cancer and the joint infections.
The key players operating the surgical stapler market involves Baseclear BV, Clinical Microbiomics A/S, Merieux Nutrisciences, Jennewein Biotechnologie, Microbiome Insights Inc., Microbiome Therapeutics LLC, MR DNA, Second Genome, Ubiome Inc., and Zymo Research Corp.